Indication
Nemaline myopathy
1 clinical trial
1 product
Clinical trial
Phase 3B Open-Label Extension Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)Status: Terminated, Estimated PCD: 2018-01-10
Product
Aceneuramic Acid